Compare · ALB vs NGVT
ALB vs NGVT
Side-by-side comparison of Albemarle Corporation (ALB) and Ingevity Corporation (NGVT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALB and NGVT operate in Major Chemicals (Industrials), so they compete in similar markets.
- ALB is the larger of the two at $20.81B, about 8.8x NGVT ($2.36B).
- Over the past year, ALB is up 216.3% and NGVT is up 63.2% - ALB leads by 153.1 points.
- ALB has been more active in the news (8 items in the past 4 weeks vs 7 for NGVT).
- ALB has more recent analyst coverage (25 ratings vs 12 for NGVT).
- Company
- Albemarle Corporation
- Ingevity Corporation
- Price
- $176.37+0.10%
- $67.59-1.63%
- Market cap
- $20.81B
- $2.36B
- 1M return
- -7.68%
- -7.30%
- 1Y return
- +216.33%
- +63.18%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NYSE
- IPO
- 2016
- News (4w)
- 8
- 7
- Recent ratings
- 25
- 12
Albemarle Corporation
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Ingevity Corporation
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia-Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the kraft pulping process and caprolactone monomers. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, coatings, resins, elastomers, bioplastics, medical devices, and other industrial applications. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Latest ALB
- SEC Form SD filed by Albemarle Corporation
- Albemarle upgraded by Vertical Research with a new price target
- Chairman & CEO Masters J Kent sold $3,011,766 worth of shares (16,393 units at $183.72), decreasing direct ownership by 16% to 87,519 units (SEC Form 4)
- SEC Form S-8 filed by Albemarle Corporation
- Albemarle Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 10-Q filed by Albemarle Corporation
- Albemarle Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Albemarle Announces Quarterly Common Stock Dividend
- Albemarle downgraded by Rothschild & Co Redburn with a new price target
- Albemarle Corporation filed SEC Form 8-K: Leadership Update
Latest NGVT
- Amendment: SEC Form SCHEDULE 13G/A filed by Ingevity Corporation
- SEC Form S-8 filed by Ingevity Corporation
- SEC Form 10-Q filed by Ingevity Corporation
- Ingevity Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Ingevity reports first quarter 2026 financial results
- SVP, Finance & CAO Platt Phillip John was granted 1,262 shares, increasing direct ownership by 4% to 31,633 units (SEC Form 4)
- Ingevity Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Fernandez-Moreno Luis M was granted 1,904 shares, increasing direct ownership by 5% to 37,882 units (SEC Form 4)
- Director Gulyas Diane H. was granted 1,904 shares, increasing direct ownership by 15% to 14,788 units (SEC Form 4)
- Director Hoechner Bruce D. was granted 1,904 shares, increasing direct ownership by 22% to 10,732 units (SEC Form 4)